| Miguel Angel Cazares, MD | |
|
3100 W Christoffersen Pkwy, Turlock, CA 95382-9547 | |
| (209) 632-3901 | |
| Not Available |
| Full Name | Miguel Angel Cazares |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 12 Years |
| Location | 3100 W Christoffersen Pkwy, Turlock, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194086207 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A132127 (California) | Primary |
| 207Q00000X | Family Medicine | A132127 (California) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sutter Medical Center, Sacramento | Sacramento, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sutter Valley Medical Foundation | 9830094515 | 1840 |
News Archive
The American College of Physicians (ACP) is offering a new, web-based tool to help guide practices through the process of becoming a patient-centered medical home (PCMH).
Researchers have discovered new small molecules that may prevent prostate cancer cells from turning off normal genes in a process that transforms normal cells into cancer cells. This significant discovery in the field of epigenetics has immediate implications in the development of new diagnostic tests and cancer medications.
CardioNet, Inc., a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, announced today that the Company entered into a definitive merger agreement with Biotel, Inc. to acquire all of the outstanding shares of Biotel for $11 million, or $3.84 per share, before adjustments for working capital. In connection with the merger agreement, the parties entered into a settlement agreement to dismiss the outstanding litigation between them, which will be effective as of the close of the merger.
Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acids (NA) and protein purification, today announced the launch of 6 novel kits for the fast and simple isolation of NA from blood, plasma/serum and urine, including cell-free-circulating (cfc)RNA, cfcDNA and sequential cfcDNA and cfcRNA.
A study from the Swedish medical university Karolinska Institutet has shown that the body's ability to break down medicines may be closely related to exposure to sunlight, and thus may vary with the seasons.
› Verified 5 days ago
| Entity Name | Sutter Valley Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669846986 PECOS PAC ID: 9830094515 Enrollment ID: O20090311000335 |
News Archive
The American College of Physicians (ACP) is offering a new, web-based tool to help guide practices through the process of becoming a patient-centered medical home (PCMH).
Researchers have discovered new small molecules that may prevent prostate cancer cells from turning off normal genes in a process that transforms normal cells into cancer cells. This significant discovery in the field of epigenetics has immediate implications in the development of new diagnostic tests and cancer medications.
CardioNet, Inc., a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, announced today that the Company entered into a definitive merger agreement with Biotel, Inc. to acquire all of the outstanding shares of Biotel for $11 million, or $3.84 per share, before adjustments for working capital. In connection with the merger agreement, the parties entered into a settlement agreement to dismiss the outstanding litigation between them, which will be effective as of the close of the merger.
Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acids (NA) and protein purification, today announced the launch of 6 novel kits for the fast and simple isolation of NA from blood, plasma/serum and urine, including cell-free-circulating (cfc)RNA, cfcDNA and sequential cfcDNA and cfcRNA.
A study from the Swedish medical university Karolinska Institutet has shown that the body's ability to break down medicines may be closely related to exposure to sunlight, and thus may vary with the seasons.
› Verified 5 days ago
| Entity Name | Emergency Physicians Urgent Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689963845 PECOS PAC ID: 8527234418 Enrollment ID: O20111227000049 |
News Archive
The American College of Physicians (ACP) is offering a new, web-based tool to help guide practices through the process of becoming a patient-centered medical home (PCMH).
Researchers have discovered new small molecules that may prevent prostate cancer cells from turning off normal genes in a process that transforms normal cells into cancer cells. This significant discovery in the field of epigenetics has immediate implications in the development of new diagnostic tests and cancer medications.
CardioNet, Inc., a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, announced today that the Company entered into a definitive merger agreement with Biotel, Inc. to acquire all of the outstanding shares of Biotel for $11 million, or $3.84 per share, before adjustments for working capital. In connection with the merger agreement, the parties entered into a settlement agreement to dismiss the outstanding litigation between them, which will be effective as of the close of the merger.
Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acids (NA) and protein purification, today announced the launch of 6 novel kits for the fast and simple isolation of NA from blood, plasma/serum and urine, including cell-free-circulating (cfc)RNA, cfcDNA and sequential cfcDNA and cfcRNA.
A study from the Swedish medical university Karolinska Institutet has shown that the body's ability to break down medicines may be closely related to exposure to sunlight, and thus may vary with the seasons.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miguel Angel Cazares, MD 600 Coffee Rd, Modesto, CA 95355-4201 Ph: (209) 521-6097 | Miguel Angel Cazares, MD 3100 W Christoffersen Pkwy, Turlock, CA 95382-9547 Ph: (209) 632-3901 |
News Archive
The American College of Physicians (ACP) is offering a new, web-based tool to help guide practices through the process of becoming a patient-centered medical home (PCMH).
Researchers have discovered new small molecules that may prevent prostate cancer cells from turning off normal genes in a process that transforms normal cells into cancer cells. This significant discovery in the field of epigenetics has immediate implications in the development of new diagnostic tests and cancer medications.
CardioNet, Inc., a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, announced today that the Company entered into a definitive merger agreement with Biotel, Inc. to acquire all of the outstanding shares of Biotel for $11 million, or $3.84 per share, before adjustments for working capital. In connection with the merger agreement, the parties entered into a settlement agreement to dismiss the outstanding litigation between them, which will be effective as of the close of the merger.
Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acids (NA) and protein purification, today announced the launch of 6 novel kits for the fast and simple isolation of NA from blood, plasma/serum and urine, including cell-free-circulating (cfc)RNA, cfcDNA and sequential cfcDNA and cfcRNA.
A study from the Swedish medical university Karolinska Institutet has shown that the body's ability to break down medicines may be closely related to exposure to sunlight, and thus may vary with the seasons.
› Verified 5 days ago
Paul Jerry Murrieta, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 825 Delbon Ave, Turlock, CA 95382 Phone: 209-342-2300 Fax: 209-524-4240 | |
Dr. Dauood Zafar Alam, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 825 Delbon Ave # Er, Turlock, CA 95382 Phone: 209-664-2790 | |
Alaud Din, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3100 W. Christoffersen Parkway, Turlock, CA 95382 Phone: 209-632-3901 | |
Gordon Elwood Alldrin, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 825 Delbon Ave, Turlock, CA 95382 Phone: 209-342-2300 Fax: 209-524-4240 | |
Arik Burgin, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 825 Delbon Ave, Turlock, CA 95382 Phone: 209-667-4200 | |
Robert K. Goh, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 825 Delbon Ave, Turlock, CA 95382 Phone: 209-664-2890 |